Cubist Systematic Strategies, LLC Cyma Bay Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $116,973 - $189,785	10,771 Added 20.82%	62,516 $932,000
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $3.58 Million - $5.25 Million	-479,636 Reduced 90.26%	51,745 $566,000
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $2.81 Million - $4.58 Million	478,052 Added 896.42%	531,381 $4.63 Million
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $363,589 - $707,983	-112,916 Reduced 67.92%	53,329 $334,000
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $318,303 - $488,371	114,911 Added 223.85%	166,245 $582,000
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $30,364 - $59,847	17,654 Added 52.42%	51,334 $151,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $25,453 - $33,447	9,189 Added 37.52%	33,680 $105,000
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $18,662 - $26,578	5,778 Added 30.88%	24,491 $83,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $156,104 - $198,842	-44,987 Reduced 70.62%	18,713 $68,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $345,695 - $431,680	-87,740 Reduced 57.94%	63,700 $278,000
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $312,432 - $483,789	73,861 Added 95.21%	151,440 $688,000
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $118,112 - $186,135	20,613 Added 36.18%	77,579 $445,000
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $136,551 - $297,781	41,130 Added 259.72%	56,966 $412,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $3,633 - $10,952	2,577 Added 19.44%	15,836 $55,000
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $9,702 - $15,679	-7,762 Reduced 36.92%	13,259 $20,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $18,719 - $83,464	-14,075 Reduced 40.1%	21,021 $41,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $71,685 - $100,947	14,001 Added 66.37%	35,096 $180,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $127,624 - $288,157	21,095 New	21,095 $151,000
Q1 2019 May 15, 2019	SELL	$8.16 - $13.42 $219,479 - $360,957	-26,897 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $131,447 - $235,962	20,099 Added 295.66%	26,897 $212,000
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $22,902 - $30,564	-2,105 Reduced 23.64%	6,798 $75,000
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $158,471 - $213,773	-14,866 Reduced 62.54%	8,903 $119,000
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $213,921 - $360,338	23,769 New	23,769 $309,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account